The Korean Journal of Urological Oncology 2015;13(1):11-16.
Published online April 30, 2015.
정위성방광대치술을 시행받은 방광암 환자의 기능적 결과 및 삶의 질
박상언1, 조강수2
1국민건강보험공단 일산병원 비뇨기과, 2연세대학교 의과대학 강남세브란스병원 비뇨기과학교실
Functional Outcomes and Quality of Life after Orthotopic Bladder Substitution in Bladder Cancer Patients
Sang Un Park 1, Kang Su Cho 2
021Department of Urology, Department of Urology, Gangnam Severance Hospital, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea
Correspondence:  Kang Su Cho
Abstract
Radical cystectomy is the golden standard treatment for muscle-invasive bladder cancer. Urinary diversion is the prerequisite procedure after cystectomy and various type of urinary diversion has been introduced. Urinary diversion carries surgical morbidities, postoperative complications in terms of urinary function and sexual function, and issues for quality of life, which are important considerations for selecting urinary diversion. Ileal conduit urinary diversion and orthotopic bladder substitution have been regarded as the representative urinary diversion after radical cystectomy. There have been great efforts to compare the functional outcomes and quality of life between these two types of urinary diversion. Although orthotopic bladder substitution seems to a more natural and desirable urinary diversion, the currently available evidence is insufficient to draw a conclusion that orthotopic bladder is an absolutely superior form of urinary diversion. However, the vast majority of studies demonstrated that orthotopic neobladder urinary diversion shows at least equal or a marginally better quality of life scores compared to ileal conduit diversion. The favorable outcomes of orthotopic neobladder would be more pronounced especially when considering relatively young and healthy patients. (Korean J Urol Oncol 2015;13:11-16)
Key Words: Urinary bladder neoplasms, Urinary diversion, Quality of life


Editorial Office
Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817,   FAX: +82-2-742-4665   Email: journal@e-juo.org
Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: kspe.editor@gmail.com

Copyright © The Korean Urological Oncology Society.

Developed in M2PI